Jul 12, 2022 / 12:00PM GMT
Operator
Good morning, and welcome to the Aldeyra Therapeutics conference call. (Operator Instructions)
I would now like to hand the conference call over to Bruce Greenberg, Vice President of Finance, Interim Chief Financial Officer and Treasurer. Thank you. Sir, please go ahead.
Bruce Greenberg - Aldeyra Therapeutics, Inc. - VP of Finance, Interim CFO & Treasurer
Thank you, and good morning, everyone. With me are President and Chief Executive Officer, Dr. Todd Brady; and Kelly Mizer, our Vice President of Commercial Strategy and Operations. Joining us on today's call is Dr. John Berdahl, a specialist in diseases of the anterior segment at Vance Thompson Vision and Professor of Ophthalmology at the Stanford School of Medicine.
This morning, we issued a press release reporting top-line results for the Crossover clinical trial of reproxalap for the treatment of dry eye disease. A copy of the press release is available on the Investors & Media section of our website, www.aldeyra.com.
Aldeyra Therapeutics Inc Call to Report Top-Line Results from the Crossover Clinical Trial of Reproxalap Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
